Northwestern Mutual Wealth Management
RNTX

Northwestern Mutual Wealth Management’s Rein Therapeutics RNTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.2K Hold
42,440
– – ﹤0.01% 2400
2025
Q4 		$49.2K Hold
42,440
– – ﹤0.01% 2405
2025
Q3 		$48.6K Sell
42,440
-6,222
-13% -$7.9K ﹤0.01% 2331
2025
Q2 		$68.1K Buy
48,662
+33,221
+215% +$59.8K ﹤0.01% 2139
2025
Q1 		$27.3K Buy
+15,441
New +$32.4K ﹤0.01% 2398

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Northwestern Mutual Wealth Management's RNTX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management held its Rein Therapeutics (RNTX) position steady in Q1 2026 at 42,440 shares worth $55.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

Northwestern Mutual Wealth Management first reported a position in RNTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $68.1K in Q2 2025. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Northwestern Mutual Wealth Management held 42,440 shares of Rein Therapeutics worth $55.2K as of Q1 2026.
  • Northwestern Mutual Wealth Management left its Rein Therapeutics share count unchanged in Q1 2026.
  • Rein Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2400 holding.
  • Northwestern Mutual Wealth Management first reported a position in Rein Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Northwestern Mutual Wealth Management's Rein Therapeutics position peaked at $68.1K in Q2 2025.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.